Founded in 1971, Yangtze River Pharmaceutical Group is a large-scale cross-region pharmaceutical group, combining production, learning, research and integrating science and trade. Products include both Chinese and Western medicines, covering over 10 fields, nearly 20 dosage forms, over 200 medicines and strengths. YRPG was awarded the certificate of ISO9001, ISO14001 and OHSAS18001 of Germany TüV Rheinland Group in 2006. Four workshops in Headquarter and subsidiaries passed inspection of EU cGMP.
Dexmedetomidine hydrochloride injection, Parecoxib sodium for injection, Lenalidomide capsules, Pemetrexed disodium for injection.
For more information, click here to view my store.
SOTIO and Cytune Pharma from the PPF Group, today presented new preclinical data highlighting the therapeutic potential of SO-C101, an IL-15 superagonist, as a monotherapy and in combination with PD-1 inhibitors in multiple tumor models.
SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced the appointment of Richard Sachse, M.D., Ph.D., as Chief Medical Officer effective July 1, 2020. Dr. Sachse brings more than 25 years of experience in the biopharma indust